Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

KRYSTAL BIOTECH, INC.

(KRYS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about KRYSTAL BIOTECH, INC.
09/16KRYSTAL BIOTECH : Guaranteed Maximum Price Amendment (Form 8-K)
PU
09/15Krystal Biotech Appoints Laurent Goux as General Manager of Europe
GL
09/09KRYSTAL BIOTECH : to Present Data on DEB and B-VEC at the DEBRA International Conference 2..
AQ
09/07KRYSTAL BIOTECH : to Participate in H.C. Wainwright 23rd Annual Global Investment Conferen..
AQ
08/09KRYSTAL BIOTECH : Q2 Loss Widens
MT
08/09Krystal Biotech, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 20..
CI
08/09KRYSTAL BIOTECH : Earnings Flash (KRYS) KRYSTAL BIOTECH Reports Q2 Loss $-0.74
MT
08/09KRYSTAL BIOTECH : Reports Second Quarter 2021 Financial Results and Provides Update on Ope..
AQ
08/03KRYSTAL BIOTECH : Jeune Aesthetics Announces Initiation of Dosing in Efficacy Cohort of KB..
PU
07/21NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
07/20KRYSTAL BIOTECH : Goldman Sachs Lifts Krystal Biotech to Buy From Neutral, Price Target to..
MT
07/01KRYSTAL BIOTECH : Provides Update on the Clinical Trial Evaluating Topical KB105 for the T..
PU
07/01KRYSTAL BIOTECH : Reports Updated Data for Prospective Treatment of TGM-1 Associated Ichth..
MT
07/01Krystal Biotech Provides Update on the Clinical Trial Evaluating Topical KB105 for the ..
GL
07/01Krystal Biotech Provides Update on the Clinical Trial Evaluating Topical KB105 for the ..
CI
06/25KRYSTAL BIOTECH, INC.(NASDAQGM : KRYS) added to Russell Small Cap Comp Value Index
CI
06/25KRYSTAL BIOTECH, INC.(NASDAQGM : KRYS) added to Russell 3000E Value Index
CI
06/25KRYSTAL BIOTECH, INC.(NASDAQGM : KRYS) added to Russell 3000 Value Index
CI
06/25KRYSTAL BIOTECH, INC.(NASDAQGM : KRYS) added to Russell 2500 Value Index
CI
06/25KRYSTAL BIOTECH, INC.(NASDAQGM : KRYS) added to Russell 2000 Value Index
CI
06/03KRYSTAL BIOTECH : to Participate in Upcoming Investor Conferences
AQ
05/12KRYSTAL BIOTECH : Reports First Quarter 2021 Financial Results and Provides Update on Oper..
PU
05/10KRYSTAL BIOTECH : Q1 Loss Expands
MT
05/10Krystal Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 20..
CI
05/10KRYSTAL BIOTECH : Reports First Quarter 2021 Financial Results and Provides Update on Oper..
AQ
05/03Krystal Biotech Appoints Andy Orth as Chief Commercial Officer
GL
05/03Krystal Biotech, Inc. Appoints Andy Orth as Chief Commercial Officer
CI
05/02Certain Stock Units of Krystal Biotech, Inc. are subject to a Lock-Up Agreement Ending ..
CI
05/02Certain Common Stock of Krystal Biotech, Inc. are subject to a Lock-Up Agreement Ending..
CI
04/27Krystal Biotech Announces Virtual Presentation of Data from its Vector-Encoded-Antibody..
GL
04/26Krystal Biotech Provides Update on Pivotal GEM-3 Study of B-VEC for DEB
GL
04/26Krystal Biotech Provides Update on Pivotal GEM-3 Study of B-VEC for DEB
CI
04/19KRYSTAL BIOTECH : Reports Positive Pre-Clinical Results for its Prospective Cystic Fibrosi..
MT
04/19Krystal Biotech Provides Updates from its Rare Genetic Lung Disease Pipeline
GL
04/19Krystal Biotech Provides Updates from its Rare Genetic Lung Disease Pipeline
CI
03/30KRYSTAL BIOTECH : Completes Enrollment of Phase 3 Study of B-VEC to Treat Dystrophic Epide..
MT
03/30Krystal Biotech Announces Completion of Patient Enrollment in the GEM-3 Pivotal Trial o..
GL
03/30Krystal Biotech, Inc. Announces Completion of Patient Enrollment in the Gem-3 Pivotal T..
CI
03/29Krystal Biotech to Participate in Upcoming Investor Conferences
GL
03/24KRYSTAL BIOTECH : Launches Aesthetic Medicines Subsidiary Jeune
MT
03/24Krystal Biotech, Inc. Announces the Launch of Juene, Inc
CI
03/24Krystal Biotech Announces Launch of Jeune, a Gene-Based Aesthetics Company, and Initial..
GL
03/02KRYSTAL BIOTECH : Chardan Adjusts Price Target on Krystal Biotech to $125 From $115, Maint..
MT
03/01KRYSTAL BIOTECH : HC Wainwright Adjusts Krystal Biotech PT to $103 From $84, Maintains Buy..
MT
03/01KRYSTAL BIOTECH : Posts Wider Q4 Loss, Still Tops Expectations; Shares Higher Monday Morni..
MT
03/01KRYSTAL BIOTECH : Earnings Flash (KRYS) KRYSTAL BIOTECH Reports Q4 EPS $-0.53
MT
03/01Krystal Biotech Provides Update on Operational Progress and Reports Fourth Quarter and ..
GL
03/01Krystal Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 202..
CI
03/01Krystal Biotech, Inc. Provides Update on Operational Progress
CI
02/23KRYSTAL BIOTECH : to Present at the Cowen 41st Annual Health Care Conference
AQ
02/09KRYSTAL BIOTECH : Jones Trading Starts Krystal Biotech at Buy With $97 Price Target
MT
02/03Wall Street Mixed in Midday Trading as Alphabet Hits Record High
MT
02/03MIDDAY REPORT : Wall Street Mixed Midday, Alphabet Hits Record High
MT
02/03Wall Street Futures Mostly Higher; US Private Payrolls Rebounded in January
MT
02/03KRYSTAL BIOTECH : Prices Upsized Common Stock Offering at $65 Per Share
MT
02/02Krystal Biotech Announces Pricing of Upsized $125 Million Public Offering of Common Sto..
GL
02/02KRYSTAL BIOTECH : Announces Proposed $100 Million Public Offering of Common Stock
BU
02/02Krystal Biotech, Inc. Enters into a Purchase and Sale Agreement with Northfield I, LLC
CI
01/08KRYSTAL BIOTECH : HC Wainwright Adjusts Krystal Biotech's Price Target to $84 From $68, Re..
MT
01/04Krystal Biotech, Inc. Announces Board Appointments
CI
01/04KRYSTAL BIOTECH : Appoints Dr. Chris Mason and Dr. Jing Marantz to its Board of Directors
BU
2020KRYSTAL BIOTECH, INC.(NASDAQGM : KRYS) added to NASDAQ Biotechnology Index
CI
2020KRYSTAL BIOTECH : to Present at the Evercore ISI HealthCONx Conference
BU
2020KRYSTAL BIOTECH : Posts Wider Q3 Loss
MT
2020KRYSTAL BIOTECH : Reports Third Quarter 2020 Financial Results and Provides Update on Oper..
BU
2020Krystal Biotech, Inc. Reports Earnings Results for the Third Quarter Ended September 30..
CI
2020KRYSTAL BIOTECH : Announces Departure of Chief Commercial Officer
BU
2020Krystal Biotech, Inc. Announces Resignation of Jennifer Chien as Chief Commercial Offic..
CI
2020KRYSTAL BIOTECH : to Present Pre-clinical Data Highlighting KB301 for Aesthetic Indication..
BU
2020Krystal Biotech Presents Pre-Clinical Data of KB301 for Aesthetic Indications
CI
2020KRYSTAL BIOTECH : to Present at Upcoming Investor Conferences
BU
2020KRYSTAL BIOTECH : to Present at HC Wainwright and Morgan Stanley Healthcare Conferences
AQ
2020Krystal Biotech to Present at HC Wainwright and Morgan Stanley Healthcare Conferences
GL
2020Krystal Biotech Announces Initiation of Phase 1 Study Evaluating KB301 in Aesthetic Ind..
GL
2020Krystal Biotech Announces Initiation of Phase 1 Study Evaluating KB301 in Aesthetic Ind..
CI
1  2  3Next
Upcoming event on KRYSTAL BIOTECH, INC.
09/30/21